Found: 3
Select item for more details and to access through your institution.
Robust physiologically based pharmacokinetic model of rifampicin for predicting drug–drug interactions via P‐glycoprotein induction and inhibition in the intestine, liver, and kidney.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2022, v. 11, n. 7, p. 919, doi. 10.1002/psp4.12807
- By:
- Publication type:
- Article
Expanded Physiologically‐Based Pharmacokinetic Model of Rifampicin for Predicting Interactions With Drugs and an Endogenous Biomarker via Complex Mechanisms Including Organic Anion Transporting Polypeptide 1B Induction.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2019, v. 8, n. 11, p. 845, doi. 10.1002/psp4.12457
- By:
- Publication type:
- Article
Comprehensive PBPK Model of Rifampicin for Quantitative Prediction of Complex Drug‐Drug Interactions: CYP3A/2C9 Induction and OATP Inhibition Effects.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2018, v. 7, n. 3, p. 186, doi. 10.1002/psp4.12275
- By:
- Publication type:
- Article